-
EC eCQMs
-
Resolution: Answered
-
Moderate
-
None
-
We plan to move forward with the proposed change during this annual update.
Brief Description of Measure:
CMS157: Oncology: Medical and Radiation - Pain Intensity Quantified:
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified
Description of Issue:
The intent of the chemotherapy required in the measure is to capture patients who are receiving on-going chemotherapy. However, with the current logic, a patient with only 2 instances of chemo which were administered on the same day meets the Initial Population 1/ Denominator 1.
Proposed Solution:
The measure steward proposes to add an 'and not' logic clause to CQL definition "Face to Face or Telehealth Encounter with Ongoing Chemotherapy" to ensure that 2 chemotherapy administrations done on the same day should not meet the two chemotherapy requirement. A patient should have two chemotherapy administrations given on different days within the timeframe specified in the measure.
The steward believes this addition will eliminate the need to include the following phrase of logic from the indicated definition:
' and ChemoBeforeEncounter !~ ChemoAfterEncounter'
CURRENT:
Face to Face or Telehealth Encounter with Ongoing Chemotherapy
from
["Encounter, Performed": "Office Visit"] FaceToFaceOrTelehealthEncounter,
"Chemotherapy Within 31 Days Prior and After Measurement Period" ChemoBeforeEncounter,
"Chemotherapy Within 31 Days Prior and After Measurement Period" ChemoAfterEncounter,
["Diagnosis": "Cancer"] Cancer
where Global."NormalizeInterval" ( ChemoBeforeEncounter.relevantDatetime, ChemoBeforeEncounter.relevantPeriod ) starts 30 days or less on or before day of
end of FaceToFaceOrTelehealthEncounter.relevantPeriod
and Global."NormalizeInterval" ( ChemoAfterEncounter.relevantDatetime, ChemoAfterEncounter.relevantPeriod ) starts 30 days or less on or after day of
end of FaceToFaceOrTelehealthEncounter.relevantPeriod
and ChemoBeforeEncounter !~ ChemoAfterEncounter
and Cancer.prevalencePeriod overlaps FaceToFaceOrTelehealthEncounter.relevantPeriod
and FaceToFaceOrTelehealthEncounter.relevantPeriod during "Measurement Period"
return FaceToFaceOrTelehealthEncounter
PROPOSED:
Face to Face or Telehealth Encounter with Ongoing Chemotherapy
from
["Encounter, Performed": "Office Visit"] FaceToFaceOrTelehealthEncounter,
"Chemotherapy Within 31 Days Prior and After Measurement Period" ChemoBeforeEncounter,
"Chemotherapy Within 31 Days Prior and After Measurement Period" ChemoAfterEncounter,
["Diagnosis": "Cancer"] Cancer
where Global."NormalizeInterval" ( ChemoBeforeEncounter.relevantDatetime, ChemoBeforeEncounter.relevantPeriod ) starts 30 days or less on or before day of
end of FaceToFaceOrTelehealthEncounter.relevantPeriod
and Global."NormalizeInterval" ( ChemoAfterEncounter.relevantDatetime, ChemoAfterEncounter.relevantPeriod ) starts 30 days or less on or after day of
end of FaceToFaceOrTelehealthEncounter.relevantPeriod
and not (Global."NormalizeInterval" ( ChemoAfterEncounter.relevantDatetime, ChemoAfterEncounter.relevantPeriod ) same day as Global."NormalizeInterval" ( ChemoBeforeEncounter.relevantDatetime, ChemoBeforeEncounter.relevantPeriod ))
and Cancer.prevalencePeriod overlaps FaceToFaceOrTelehealthEncounter.relevantPeriod
and FaceToFaceOrTelehealthEncounter.relevantPeriod during "Measurement Period"
return FaceToFaceOrTelehealthEncounter
Rationale for Change:
The proposed change is to capture the chemotherapy requirements appropriately and align with the measure intent.